Skip to main navigation
Skip to search
Skip to main content
Keio University Home
Help & FAQ
Link opens in a new tab
English
日本語
Search content at Keio University
Home
Profiles
Research units
Research output
Evidence-based clinical practice guidelines for liver cirrhosis 2015
Hiroshi Fukui
, Hidetsugu Saito
, Yoshiyuki Ueno
, Hirofumi Uto
, Katsutoshi Obara
, Isao Sakaida
, Akitaka Shibuya
, Masataka Seike
, Sumiko Nagoshi
, Makoto Segawa
, Hirohito Tsubouchi
, Hisataka Moriwaki
, Akinobu Kato
, Etsuko Hashimoto
, Kojiro Michitaka
, Toshikazu Murawaki
, Kentaro Sugano
, Mamoru Watanabe
, Tooru Shimosegawa
School of Pharmacy
Research output
:
Contribution to journal
›
Review article
›
peer-review
270
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Evidence-based clinical practice guidelines for liver cirrhosis 2015'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Liver Cirrhosis
100%
Evidence-based Clinical Practice Guideline
100%
Beta-blockers
25%
Renal Failure
25%
V2 Receptor Antagonist
25%
Disaccharides
25%
Anticoagulant Therapy
25%
Esophageal Varices
25%
Endoscopic Injection Sclerotherapy
25%
Quality of Life
25%
Hepatitis C
25%
Evaluation System
25%
Hepatic Encephalopathy
25%
Literature Search
25%
Ascites
25%
Add-on Therapy
25%
Portal Vein Thrombosis
25%
Primary Biliary Cirrhosis
25%
Paracentesis
25%
MEDLINE
25%
Nucleoside Analogues
25%
Variceal Bleeding
25%
Autoimmune Hepatitis
25%
Encephalopathy
25%
Liver Hepatitis
25%
Assessment System
25%
Acute Onset
25%
Diuretic Therapy
25%
Developmental Systems
25%
Grading of Recommendations
25%
Branched-chain Amino Acids
25%
Hypoalbuminemia
25%
Decompensated Cirrhosis
25%
Cochrane
25%
Balloon-occluded Retrograde Transvenous Obliteration (B-RTO)
25%
Gastric Varices
25%
Non-absorbable Antibiotic
25%
Pegylated Interferon Plus Ribavirin
25%
Circulatory Disturbances
25%
Cyanoacrylate
25%
Primary Prophylaxis
25%
Rifaximin
25%
Tolvaptan
25%
Albumin Infusion
25%
Obturation
25%
Hepatitis B Cirrhosis
25%
Direct-acting Antivirals
25%
Assessment Development
25%
Assessment Evaluation
25%
Esophageal Variceal Bleeding
25%
Medicine and Dentistry
Liver Cirrhosis
100%
Bleeding
20%
Beta Adrenergic Receptor Blocking Agent
20%
Quality of Life
20%
Ischemia
20%
Peginterferon
20%
Combination Therapy
20%
Ribavirin
20%
Infusion
20%
Anticoagulant Therapy
20%
Sclerotherapy
20%
Esophageal Varices
20%
Renal Failure
20%
Hepatic Encephalopathy
20%
Ascites
20%
Add on Therapy
20%
Receptor Antagonist
20%
Portal Vein Thrombosis
20%
Paracentesis
20%
Disaccharide
20%
Autoimmune Hepatitis
20%
Brain Disease
20%
Hepatitis C
20%
Hepatitis B Virus
20%
Primary Biliary Cirrhosis
20%
Diuretic Therapy
20%
Branched Chain Amino Acid
20%
Injection
20%
Hypoalbuminemia
20%
Albumin
20%
Steroids
20%
Stomach Varices
20%
Vasopressin V2 Receptor
20%
Cyanoacrylate
20%
Compensated Liver Cirrhosis
20%
Rifaximin
20%
Tolvaptan
20%
Antimicrobial Agent
20%
Nucleoside Analog
20%
Antiviral Drug
20%
Obturation
20%